Literature DB >> 29544586

Large Cell Carcinoma with Adenocarcinoma in Lung.

Mustafa Kupeli1, Resit Dogan Koseoglu2.   

Abstract

Large cell neuroendocrine carcinoma (LCNC) is a rare and aggressive cancer accounting for 3% of all lung cancers. A small percentage of LCNC called combined LCNC, can be seen in combinations with other lung tumor types. Multimodal therapy is proposed for this type of tumor but there is no any significant therapy since it is very rare tumor. This patient was a 66-year male and a heavy smoker with no symptoms of lung disease. Computed tomography core biopsy showed suspected adenocarcinoma. Right lower lobectomy was performed with mediastinal lymph node dissection via mini thoracotomy. The tumor was diagnosed as combined LCNC with adenocarcinoma. The patient was discharged on the seventh postoperative day and sent to the oncology clinic for chemotherapy. There has been no recurrence for eight months after surgery.

Entities:  

Mesh:

Year:  2018        PMID: 29544586     DOI: 10.29271/jcpsp.2018.03.240

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  1 in total

1.  Clinical characteristics and treatments of large cell lung carcinoma: a retrospective study using SEER data.

Authors:  Qidong Tai; Lei Zhang; Xuefei Hu
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.